My February 1st tranche has just a few weeks left to run. It has been a struggle - although I guess +16.5% is not bad. VEC and DEPO were both huge winners at one point. VEC was up 60% in August. DEPO was up 60% in September. I came so close to selling some DEPO calls around then, I think I actually placed an order.
PERI is the lead weight. Doing the math, if you have one stock down 30%, it is tough to soar like an eagle. I really liked them at the time. They had just had an acquisition and I felt the market was not valuing it correctly. But they struggled to make money. The "turnaround" has always been a couple quarters away. That being said, PERI has moved up a lot (on % basis) of late. It actually "broke a buck" at the end of October and is now $1.65. So a 65% gain in 3 months. Entry point is everything.
Here is the tranche:
|2/1/2016||Start||Current||Dividend||Pct Gain||R3K Gain|
If I had just renewed my February 2015 tranche, I'd be on par with market (up 21%). My rejects are about the same as picks (up 15%). HPQ and BRCD are both up 55%, but LCI, CBI and VIAB are all down around 15%.
With recent run-up in MFI stocks, I am struggling a bit to find value.
IDCC, LEA, SSNI, AKRX, GHC, WNC, ABBV, MYGN, KLAC and OMC,
A lot can still happen. Stay tuned.